» Articles » PMID: 12183241

Effects of Neutrophils on Cefazolin Activity and Penicillin-binding Proteins in Staphylococcus Aureus Abscesses

Overview
Specialty Pharmacology
Date 2002 Aug 17
PMID 12183241
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteria survive within abscesses despite antimicrobial therapy, usually necessitating drainage. Our previous work showed that bacterial killing is diminished within the neutrophils of animals with abscesses. To further assess the role of neutrophils in Staphylococcus aureus survival and the poor activities of beta-lactams in abscesses, tissue cage abscess-bearing rats were given polymorphonuclear leukocyte (PMN)-depleting antibody prior to and several times following inoculation of the tissue cages with S. aureus. Cefazolin (300 mg/kg of body weight/day) was administered to all animals in appropriately divided doses. After 7 days of antimicrobial therapy, the 17 animals that received anti-PMN serum had significantly fewer abscess neutrophils than the 18 controls and fewer abscess bacteria (5.55 versus 3.79 log(10) CFU/ml [P = 0.04]) than the 18 controls. The data were consistent with the premise that cefazolin is more effective in abscesses depleted of neutrophils. To investigate further, S. aureus was incubated with rat peritoneal neutrophils; and bacterial cell membrane proteins were isolated, labeled with biotinylated ampicillin, separated by electrophoresis, blotted onto nitrocellulose, and stained for biotin reactivity. PBP 2 expression was consistently and significantly decreased after a brief, nonkilling PMN exposure. These experiments showed that PMN depletion enhanced the activity of cefazolin in the abscess milieu. Furthermore, altered bacterial cell wall cefazolin targets may be the mechanism by which the PMN diminishes antimicrobial activity, suggesting the importance of the staphylococcus-PMN interaction in the outcome of established infections.

Citing Articles

Isolated Pulmonary Valve Infective Endocarditis With Persistent Staphylococcus aureus Bacteremia and Rapid Clearance With Ertapenem Plus Cefazolin.

Fernandes P, Maia Oliveira J, Rocha A, Carvalho S, Vaz J Cureus. 2025; 17(1):e77335.

PMID: 39935929 PMC: 11813253. DOI: 10.7759/cureus.77335.


Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity.

Mondeme M, Carnoy C, Sirard J, Faveeuw C Infect Immun. 2023; 91(2):e0050322.

PMID: 36695576 PMC: 9933636. DOI: 10.1128/iai.00503-22.


Persistent Methicillin-Susceptible Bacteremia Rapidly Cleared with Cefazolin and Ertapenem Combination Therapy in a Patient with COVID-19.

Ilges D, Krishnan G, Geng E Case Rep Infect Dis. 2022; 2022:6828538.

PMID: 35462678 PMC: 9020139. DOI: 10.1155/2022/6828538.


Clearance of Persistent Bacteremia in a Preterm Neonate With the Use of Combination Cefazolin and Ertapenem.

Akers S, Kinney K, Butcher M, Moise A J Pediatr Pharmacol Ther. 2020; 25(6):547-551.

PMID: 32839659 PMC: 7439943. DOI: 10.5863/1551-6776-25.6.547.


Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Ulloa E, Singh K, Geriak M, Haddad F, Murray B, Nizet V Clin Infect Dis. 2019; 71(6):1413-1418.

PMID: 31773134 PMC: 7486850. DOI: 10.1093/cid/ciz995.


References
1.
Fields M, Herndon B, Bamberger D . beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses. Antimicrob Agents Chemother. 1993; 37(2):203-6. PMC: 187639. DOI: 10.1128/AAC.37.2.203. View

2.
Bamberger D, Fields M, Herndon B . Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing. Antimicrob Agents Chemother. 1991; 35(11):2335-9. PMC: 245381. DOI: 10.1128/AAC.35.11.2335. View

3.
Rakita R, Michel B, Rosen H . Inactivation of Escherichia coli penicillin-binding proteins by human neutrophils. Infect Immun. 1994; 62(1):162-5. PMC: 186081. DOI: 10.1128/iai.62.1.162-165.1994. View

4.
Dargis M, Malouin F . Use of biotinylated beta-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria. Antimicrob Agents Chemother. 1994; 38(5):973-80. PMC: 188136. DOI: 10.1128/AAC.38.5.973. View

5.
Henze U, Berger-Bachi B . Penicillin-binding protein 4 overproduction increases beta-lactam resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1996; 40(9):2121-5. PMC: 163484. DOI: 10.1128/AAC.40.9.2121. View